SAM RHOADES: Open Payments
NPI 1619691748 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$232 in 12 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $268 · 2025 $232
Food & beverage: $232
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $48 |
| AKEBIA THERAPEUTICS INC | 1 | $29 |
| Collegium Pharmaceutical, Inc. | 2 | $27 |
| Novo Nordisk Inc | 1 | $22 |
| Fresenius USA Marketing, Inc. | 1 | $22 |
| ABBVIE INC. | 1 | $20 |
| Ardelyx, Inc. | 1 | $18 |
| Amgen Inc. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| Antares Pharma, Inc. | 1 | $14 |
Products named: VOYXACT, Vafseo, Ozempic, VELPHORO, QULIPTA, IBSRELA, TAVNEOS, FARXIGA.
Industry payments across IN — which companies pay providers there.
